Literature DB >> 1252848

Renal disease in rheumatoid arthritis.

P A Dieppe, D V Doyle, H C Burry, S M Tucker.   

Abstract

N-Acetyl-beta-D-glucosaminidase (NAG) is a sensitive indicator of renal damage. When the urinary NAG levels of 60 patients with rheumatoid arthritis (RA) were measured a highly significant difference was detected between the mean urinary NAG excretion of the patients with RA (341 +/- 294-92 nmol h-1 mg creatinine-1) and that of 60 matched controls (67-53 +/- 16-93 nmol h-1 mg creatinine-1). In 10 patients studied no correlation could be shown between the urinary NAG levels and levels in either serum or synovial fluid. A significant positive correlation was noted between urinary NAG excretion and disease activity as estimated by the Lansbury activity index, the Ritchie articular index, and the haemaglobin level. An abnormally raised urinary NAG excretion was detected in eight out of 20 previously untreated patients with RA, which suggested that the rheumatoid process may affect renal function.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1252848      PMCID: PMC1639063          DOI: 10.1136/bmj.1.6010.611

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  Editorial: Attitude to pain.

Authors: 
Journal:  Br Med J       Date:  1975-08-02

2.  Report of a three-year study on the systemic and articular indexes in rheumatoid arthritis; theoretic and clinical considerations.

Authors:  J LANSBURY
Journal:  Arthritis Rheum       Date:  1958-12

3.  ARA NOMENCLATURE AND CLASSIFICATION OF ARTHRITIS AND RHEUMATISM (TENTATIVE).

Authors:  B S BLUMBERG; J J BUNIM; E CALKINS; C L PIRANI; N J ZVAIFLER
Journal:  Arthritis Rheum       Date:  1964-02

4.  Raised beta-acetylglucosaminidase in connective-tissue disorders: an index of inflammation?

Authors:  N C Kar; C M Pearson
Journal:  Lancet       Date:  1973-06-23       Impact factor: 79.321

5.  Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors:  D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal:  Q J Med       Date:  1968-07

6.  Renal abnormalities in rheumatoid arthritis.

Authors:  R J Bulger; L A Healey; P Polinsky
Journal:  Ann Rheum Dis       Date:  1968-07       Impact factor: 19.103

7.  Reduced glomerular function in rheumatoid arthritis.

Authors:  H C Burry
Journal:  Ann Rheum Dis       Date:  1972-01       Impact factor: 19.103

8.  A study of beta-acetylglucosaminase and acid phosphatase in pathological joint fluids.

Authors:  J C Caygill; D A Pitkeathly
Journal:  Ann Rheum Dis       Date:  1966-03       Impact factor: 19.103

9.  The use of beta-N-acetylglucosaminidase excretion to investigate renal disease in rheumatoid arthritis.

Authors:  P A Dieppe; S M Tucker; H C Burry
Journal:  Rheumatol Rehabil       Date:  1975-11

10.  Urinary N-acetyl- beta-D-glucosaminidase activities in patients with renal disease.

Authors:  J M Wellwood; B G Ellis; R G Price; K Hammond; A E Thompson; N F Jones
Journal:  Br Med J       Date:  1975-08-16
View more
  4 in total

1.  A prospective study of renal disease in patients with early rheumatoid arthritis.

Authors:  Y Koseki; C Terai; M Moriguchi; M Uesato; N Kamatani
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

Review 2.  Analgesic nephropathy: a reassessment of the role of phenacetin and other analgesics.

Authors:  L F Prescott
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

3.  The role of microalbuminuria as a predictor of subclinical cardiovascular events in rheumatoid arthritis patients and its relation to disease activity.

Authors:  D W Nada; S El Morsy; M H Abu-Zaid; M A Aboelhawa; Mohammad A Zakaria; E A El Sheikh; R A Gaber
Journal:  Clin Rheumatol       Date:  2017-10-23       Impact factor: 2.980

4.  Microalbuminuria in patients with rheumatoid arthritis.

Authors:  L M Pedersen; H Nordin; B Svensson; H Bliddal
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.